Publication: The treatment of severe malaria
Issued Date
2007-07-01
Resource Type
ISSN
00359203
Other identifier(s)
2-s2.0-34248142148
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Transactions of the Royal Society of Tropical Medicine and Hygiene. Vol.101, No.7 (2007), 633-634
Suggested Citation
Arjen M. Dondorp, N. P J Day The treatment of severe malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene. Vol.101, No.7 (2007), 633-634. doi:10.1016/j.trstmh.2007.03.011 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/24531
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
The treatment of severe malaria
Author(s)
Other Contributor(s)
Abstract
In the SEAQUAMAT trial, parenteral artesunate was shown to be associated with a considerably lower mortality than quinine, and is now the recommended treatment for severe malaria in low-transmission areas and in the second and third trimesters of pregnancy. A trial is underway to establish its role in African children. The development of artesunate suppositories may provide the means to treat patients with severe disease in remote rural settings, potentially buying the time needed to reach a health care facility. The increasing availability of basic intensive care facilities in developing countries also has the potential to further reduce mortality. © 2007 Royal Society of Tropical Medicine and Hygiene.